 |
Eikon Therapeutics
Roger Perlmutter, CEO
USA | Funding: $1.1B (+)
Website: https://www.eikontx.com/
Eikon is pioneering a new method of drug discovery based on tracking and measuring the movement of individual proteins in living cells.
Website: https://www.eikontx.com/
Eikon is pioneering a new method of drug discovery based on tracking and measuring the movement of individual proteins in living cells.
